The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
90308345 9030834 5 F 201105 20160818 20130123 20160826 EXP JP-ROCHE-1181720 ROCHE UENO C, SAWA M, SUZUKI M, NISHIDA K, GOMI F A CASE OF AGE-RELATED MACULAR DEGENERATION SHOWING RAPID EXPANSION OF CHORIORETINAL ATROPHY AFTER INTRAVITREOUS. THE 51ST ANNUAL MEETING OF JAPANESE RETINA AND VITREOUS SOCIETY 2012;:85-. 71.33 YR M Y 0.00000 20160826 MD JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
90308345 9030834 1 PS Ranibizumab RANIBIZUMAB 1 Other 125156 .05 ML SOLUTION FOR INJECTION
90308345 9030834 2 SS Ranibizumab RANIBIZUMAB 1 Other 125156 .05 ML SOLUTION FOR INJECTION
90308345 9030834 3 SS Ranibizumab RANIBIZUMAB 1 Other 125156 .05 ML SOLUTION FOR INJECTION
90308345 9030834 4 SS Ranibizumab RANIBIZUMAB 1 Other 125156 .05 ML SOLUTION FOR INJECTION
90308345 9030834 5 SS Ranibizumab RANIBIZUMAB 1 Other 125156 .05 ML SOLUTION FOR INJECTION
90308345 9030834 6 SS Ranibizumab RANIBIZUMAB 1 Other 125156 .05 ML SOLUTION FOR INJECTION
90308345 9030834 7 SS Ranibizumab RANIBIZUMAB 1 Other 125156 .05 ML SOLUTION FOR INJECTION
90308345 9030834 8 C CRAVIT LEVOFLOXACIN 1 Unknown 0
90308345 9030834 9 C CRAVIT LEVOFLOXACIN 1 Sunconjunctival 0
90308345 9030834 10 C CRAVIT LEVOFLOXACIN 1 Sunconjunctival 0
90308345 9030834 11 C CRAVIT LEVOFLOXACIN 1 Sunconjunctival 0
90308345 9030834 12 C CRAVIT LEVOFLOXACIN 1 Sunconjunctival 0
90308345 9030834 13 C CRAVIT LEVOFLOXACIN 1 Sunconjunctival 0
90308345 9030834 14 C CRAVIT LEVOFLOXACIN 1 Sunconjunctival 0
90308345 9030834 15 C HYDREA HYDROXYUREA 1 Unknown 0 1000 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
90308345 9030834 1 Age-related macular degeneration
90308345 9030834 15 Chronic myeloid leukaemia

Outcome of event

Event ID CASEID OUTC COD
90308345 9030834 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
90308345 9030834 Chorioretinal atrophy
90308345 9030834 Macular degeneration
90308345 9030834 Optic disc disorder
90308345 9030834 Retinal exudates
90308345 9030834 Visual acuity reduced
90308345 9030834 Visual field defect

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
90308345 9030834 1 20110215 0
90308345 9030834 2 20110315 0
90308345 9030834 3 20110412 20110412 0
90308345 9030834 4 20110719 0
90308345 9030834 5 20111011 0
90308345 9030834 6 20120228 0
90308345 9030834 7 20120605 0
90308345 9030834 8 201102 201102 0
90308345 9030834 9 201103 201103 0
90308345 9030834 10 201104 201104 0
90308345 9030834 11 201107 201107 0
90308345 9030834 12 201110 201110 0
90308345 9030834 13 201202 201202 0
90308345 9030834 14 201206 201206 0